XML 93 R74.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 01, 2025
Apr. 08, 2021
Oct. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2018
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Shares available for future grants (in shares)       5,976,157 7,285,275  
Number of shares reserved for issuance (in shares)       9,224,762    
Weighted-average grant date fair value (in usd per share)       $ 0.85 $ 2.66  
Aggregate intrinsic value of stock options exercised       $ 200 $ 400  
Unrecognized compensation cost related to options       600 3,100  
Share based compensation expense       $ 468 4,709  
RSU's            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Vesting period     7 days      
Weighted-average period over which unrecognized compensation cost is expected to be recognized       8 months 12 days    
Awards granted (in shares)     886,018 886,018    
Grant fair value of awards     $ 1,300      
Share based compensation expense       $ 500 $ 0  
Unrecognized compensation expense       $ 800    
Stock options            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Weighted-average period over which unrecognized compensation cost is expected to be recognized       1 year 5 months 1 day 1 year 5 months 15 days  
Barinthus Biotherapeutics plc Share Award Plan 2021 | Restricted share units, options, share appreciation rights and restricted shares            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Shares available for issuance (in shares)   3,675,680        
Percentage of issued and outstanding ordinary shares available for issuance   4.00%        
Additional number of shares available for issuance (in shares) 1,609,386          
Expiration period   10 years        
Vesting period   3 years        
Shares available for future grants (in shares)       3,248,605 1,906,080  
Enterprise Management Incentive Share Option Scheme            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Vesting period           3 years
Expiration term           10 years
Enterprise Management Incentive Share Option Scheme | RSU's            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of shares reserved for issuance (in shares)           3,530,634